Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TX-SMILE: Intra-lymphatic Immunotherapy for Mountain Cedar Allergy
NCT03682965Phase 2Completed
- Start
- Sep 2018
- Primary completion
- Mar 2019
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of juniperus ashei pollen extract in allergic rhinitis (AR), allergic conjunctivitis (AC). Started Sep 2018; status: completed.
02
Drugs
juniperus ashei pollen extract
03
Conditions
allergic rhinitis (AR)allergic conjunctivitis (AC)
Beyond the preview
Go deeper on NCT03682965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03682965.